New York Life Investment Management »

Sarepta Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Sarepta Therapeutics (SRPT) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Sarepta Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $959k 9.9k 96.43
2023-09-30 $1.2M 9.8k 121.22
2023-06-30 $523k 4.6k 114.52

More positions owned by New York Life Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Amazon (AMZN)
Indexiq Etf Tr Candriam Us Mid (IQSM)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Interna (IQSI)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Sarepta Therapeutics

Vanguard Group
Henderson Group
venBio Select Advisor
Wellington Management Company
Citadel Advisors
Bank of New York Mellon
Deutsche Bank Aktiengesellschaft
Jpmorgan Chase & Co
Bank of America Corporation
Caption Management
Casdin Capital
Norges Bank Investment Management
EcoR1 Capital
Royal Bank of Canada
Millennium Management

View all funds holding Sarepta Therapeutics